Nkarta Management
Management criteria checks 3/4
Nkarta's CEO is Paul Hastings, appointed in Feb 2018, has a tenure of 6.17 years. total yearly compensation is $4.74M, comprised of 12.6% salary and 87.4% bonuses, including company stock and options. directly owns 0.1% of the company’s shares, worth $557.45K. The average tenure of the management team and the board of directors is 4.2 years and 4.4 years respectively.
Key information
Paul Hastings
Chief executive officer
US$4.7m
Total compensation
| CEO salary percentage | 12.6% |
| CEO tenure | 6.2yrs |
| CEO ownership | 0.1% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Nkarta: NK Cell Therapy Advancement On Two Fronts
Mar 25Nkarta: Possible Upside From H1 Update, If Positive
Jan 25Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Jan 16
We're Keeping An Eye On Nkarta's (NASDAQ:NKTX) Cash Burn Rate
Oct 04We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Jun 21We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Mar 06Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Nov 20Nkarta GAAP EPS of -$0.61
Aug 11We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate
Jun 09Nkarta: A Promising Natural Killer Cell Play
May 20We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Aug 23Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans
May 10Nkarta gets greenlight from the FDA for NKX019 cancer study
Apr 28We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate
Jan 25
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$122m |
| Jun 30 2023 | n/a | n/a | -US$125m |
| Mar 31 2023 | n/a | n/a | -US$119m |
| Dec 31 2022 | US$5m | US$600k | -US$114m |
| Sep 30 2022 | n/a | n/a | -US$104m |
| Jun 30 2022 | n/a | n/a | -US$98m |
| Mar 31 2022 | n/a | n/a | -US$93m |
| Dec 31 2021 | US$7m | US$576k | -US$86m |
| Sep 30 2021 | n/a | n/a | -US$81m |
| Jun 30 2021 | n/a | n/a | -US$72m |
| Mar 31 2021 | n/a | n/a | -US$102m |
| Dec 31 2020 | US$3m | US$560k | -US$91m |
| Sep 30 2020 | n/a | n/a | -US$84m |
| Jun 30 2020 | n/a | n/a | -US$73m |
| Mar 31 2020 | n/a | n/a | -US$27m |
| Dec 31 2019 | US$3m | US$543k | -US$21m |
Compensation vs Market: Paul's total compensation ($USD4.74M) is above average for companies of similar size in the US market ($USD2.43M).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul Hastings (63 yo)
6.2yrs
Tenure
US$4,744,750
Compensation
Mr. Paul J. Hastings serves as its Chair of the Board of Pacira BioSciences, Inc. (formerly known as Pacira Pharmaceuticals, Inc.) since January 02, 2024 and served as its Lead Director since June 2013. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 6.2yrs | US$4.74m | 0.10% $ 557.5k | |
| Chief Legal Officer & Corporate Secretary | 3.5yrs | US$2.06m | 0.016% $ 88.9k | |
| Chief Financial & Business Officer and Principal Accounting Officer | less than a year | no data | no data | |
| Chief Technical Officer | 4.3yrs | no data | 0.0053% $ 28.8k | |
| Chief Scientific Officer | 4.3yrs | no data | 0.078% $ 429.5k | |
| Vice President of Public Affairs and Investor Relations | 4.2yrs | no data | no data | |
| Chief Medical Officer | 1.3yrs | no data | 0.021% $ 117.0k |
4.2yrs
Average Tenure
53.5yo
Average Age
Experienced Management: NKTX's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 6.2yrs | US$4.74m | 0.10% $ 557.5k | |
| Independent Director | 4.7yrs | US$205.99k | 0% $ 0 | |
| Independent Chairman | 8.5yrs | US$243.99k | 0% $ 0 | |
| Independent Director | 4yrs | US$213.49k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.7yrs | US$212.49k | 0% $ 0 | |
| Independent Director | 4.2yrs | US$203.49k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.2yrs | US$202.49k | 0% $ 0 | |
| Independent Director | 2.1yrs | US$302.47k | 0% $ 0 |
4.4yrs
Average Tenure
47.5yo
Average Age
Experienced Board: NKTX's board of directors are considered experienced (4.4 years average tenure).